80 related articles for article (PubMed ID: 22226443)
1. Evaluation of the screening power of Cognitive Abilities Screening Instrument for probable Alzheimer's disease using voxel-based morphometry.
Mok GS; Wu YY; Lu KM; Wu J; Chen LK; Wu TH
Clin Imaging; 2012; 36(1):46-53. PubMed ID: 22226443
[TBL] [Abstract][Full Text] [Related]
2. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease.
Testa C; Laakso MP; Sabattoli F; Rossi R; Beltramello A; Soininen H; Frisoni GB
J Magn Reson Imaging; 2004 Mar; 19(3):274-82. PubMed ID: 14994294
[TBL] [Abstract][Full Text] [Related]
3. [Voxel-based morphometric study of brain structure in Alzheimer's disease].
Yuan Q; Zou L; Chen Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):496-9. PubMed ID: 18575352
[TBL] [Abstract][Full Text] [Related]
4. Voxel-based morphometry to discriminate early Alzheimer's disease from controls.
Hirata Y; Matsuda H; Nemoto K; Ohnishi T; Hirao K; Yamashita F; Asada T; Iwabuchi S; Samejima H
Neurosci Lett; 2005 Jul; 382(3):269-74. PubMed ID: 15925102
[TBL] [Abstract][Full Text] [Related]
5. [Multi-modality magnetic resonance imaging features of cognitive function in mild cognitive impairment].
Wang HL; Yuan HS; Su LM; Zhu Y; Liao J; Zhang MY; Li T; Yu X
Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):680-3. PubMed ID: 20979788
[TBL] [Abstract][Full Text] [Related]
6. Correlation between gray matter volume in the temporal lobe and depressive symptoms in patients with Alzheimer's disease.
Son JH; Han DH; Min KJ; Kee BS
Neurosci Lett; 2013 Aug; 548():15-20. PubMed ID: 23727389
[TBL] [Abstract][Full Text] [Related]
7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
8. Volumetric reduction of the corpus callosum in Alzheimer's disease in vivo as assessed with voxel-based morphometry.
Chaim TM; Duran FL; Uchida RR; Périco CA; de Castro CC; Busatto GF
Psychiatry Res; 2007 Jan; 154(1):59-68. PubMed ID: 17174533
[TBL] [Abstract][Full Text] [Related]
9. Improving the screening power of the cognitive abilities screening instrument, Chinese version.
Tsai RC; Lin KN; Wu KY; Liu HC
Dement Geriatr Cogn Disord; 2004; 18(3-4):314-20. PubMed ID: 15305109
[TBL] [Abstract][Full Text] [Related]
10. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
11. Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer's disease with normal control comparison.
Chang YT; Chang CC; Lin HS; Huang CW; Chang WN; Lui CC; Lee CC; Lin YT; Chen CH; Chen NC
Acta Neurol Taiwan; 2012 Jun; 21(2):64-73. PubMed ID: 22879115
[TBL] [Abstract][Full Text] [Related]
12. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment.
Bozzali M; Filippi M; Magnani G; Cercignani M; Franceschi M; Schiatti E; Castiglioni S; Mossini R; Falautano M; Scotti G; Comi G; Falini A
Neurology; 2006 Aug; 67(3):453-60. PubMed ID: 16894107
[TBL] [Abstract][Full Text] [Related]
13. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study.
Chételat G; Landeau B; Eustache F; Mézenge F; Viader F; de la Sayette V; Desgranges B; Baron JC
Neuroimage; 2005 Oct; 27(4):934-46. PubMed ID: 15979341
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
[TBL] [Abstract][Full Text] [Related]
15. Structural changes of the corpus callosum in mild cognitive impairment and Alzheimer's disease.
Thomann PA; Wustenberg T; Pantel J; Essig M; Schroder J
Dement Geriatr Cogn Disord; 2006; 21(4):215-20. PubMed ID: 16415572
[TBL] [Abstract][Full Text] [Related]
16. Voxel-based morphometry in Alzheimer's disease.
Busatto GF; Diniz BS; Zanetti MV
Expert Rev Neurother; 2008 Nov; 8(11):1691-702. PubMed ID: 18986240
[TBL] [Abstract][Full Text] [Related]
17. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer's disease.
van Es AC; van der Flier WM; Admiraal-Behloul F; Olofsen H; Bollen EL; Middelkoop HA; Weverling-Rijnsburger AW; Westendorp RG; van Buchem MA
Neurobiol Aging; 2006 Dec; 27(12):1757-62. PubMed ID: 16290268
[TBL] [Abstract][Full Text] [Related]
18. Automated method for identification of patients with Alzheimer's disease based on three-dimensional MR images.
Arimura H; Yoshiura T; Kumazawa S; Tanaka K; Koga H; Mihara F; Honda H; Sakai S; Toyofuku F; Higashida Y
Acad Radiol; 2008 Mar; 15(3):274-84. PubMed ID: 18280925
[TBL] [Abstract][Full Text] [Related]
19. Clock drawing performance and brain morphology in mild cognitive impairment and Alzheimer's disease.
Thomann PA; Toro P; Dos Santos V; Essig M; Schröder J
Brain Cogn; 2008 Jun; 67(1):88-93. PubMed ID: 18215449
[TBL] [Abstract][Full Text] [Related]
20. Multicenter assessment of reliability of cranial MRI.
Ewers M; Teipel SJ; Dietrich O; Schönberg SO; Jessen F; Heun R; Scheltens P; van de Pol L; Freymann NR; Moeller HJ; Hampel H
Neurobiol Aging; 2006 Aug; 27(8):1051-9. PubMed ID: 16169126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
